No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr9:110347200-110350600 |
Weak transcription |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
2 |
chr9:110348200-110350200 |
Weak transcription |
Gastric |
stomach
|
3 |
chr9:110348800-110350000 |
Enhancers |
Left Ventricle |
heart
|
4 |
chr9:110348800-110350200 |
Enhancers |
Spleen |
Spleen
|
5 |
chr9:110349000-110352200 |
Enhancers |
Lung |
lung
|
6 |
chr9:110349400-110350400 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
7 |
chr9:110349400-110350400 |
Enhancers |
Fetal Muscle Leg |
muscle
|
8 |
chr9:110349400-110350800 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
9 |
chr9:110349600-110350000 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
10 |
chr9:110349600-110350000 |
Flanking Active TSS |
Pancreas |
Pancrea
|
11 |
chr9:110349600-110350000 |
Enhancers |
NHEK |
skin
|
12 |
chr9:110349600-110350200 |
Enhancers |
Stomach Mucosa |
stomach
|
13 |
chr9:110349600-110350400 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
14 |
chr9:110349600-110350400 |
Flanking Active TSS |
Primary monocytes fromperipheralblood |
blood
|
15 |
chr9:110349600-110350400 |
Flanking Active TSS |
Primary neutrophils fromperipheralblood |
blood
|
16 |
chr9:110349600-110350400 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
17 |
chr9:110349600-110350400 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
18 |
chr9:110349600-110350400 |
Flanking Active TSS |
Liver |
Liver
|
19 |
chr9:110349600-110350400 |
Flanking Active TSS |
Fetal Intestine Small |
intestine
|
20 |
chr9:110349600-110350400 |
Active TSS |
Rectal Smooth Muscle |
rectum
|
21 |
chr9:110349600-110350400 |
Flanking Bivalent TSS/Enh |
HepG2 |
liver
|
22 |
chr9:110349600-110350400 |
Active TSS |
Osteobl |
bone
|
23 |
chr9:110349600-110350600 |
Active TSS |
Brain Hippocampus Middle |
brain
|
24 |
chr9:110349600-110350600 |
Flanking Active TSS |
Fetal Intestine Large |
intestine
|
25 |
chr9:110349600-110350600 |
Flanking Active TSS |
HUVEC |
blood vessel
|
26 |
chr9:110349800-110350000 |
Enhancers |
Primary mononuclear cells fromperipheralblood |
Blood
|
27 |
chr9:110349800-110350200 |
Active TSS |
Primary hematopoietic stem cells |
blood
|
28 |
chr9:110349800-110350200 |
Flanking Bivalent TSS/Enh |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
29 |
chr9:110349800-110350200 |
Active TSS |
Adipose Nuclei |
Adipose
|
30 |
chr9:110349800-110350200 |
Active TSS |
Colonic Mucosa |
Colon
|
31 |
chr9:110349800-110350200 |
Active TSS |
Duodenum Mucosa |
Duodenum
|
32 |
chr9:110349800-110350200 |
Active TSS |
Rectal Mucosa Donor 29 |
rectum
|
33 |
chr9:110349800-110350200 |
Active TSS |
Rectal Mucosa Donor 31 |
rectum
|
34 |
chr9:110349800-110350400 |
Active TSS |
Aorta |
Aorta
|
35 |
chr9:110349800-110350400 |
Active TSS |
Duodenum Smooth Muscle |
Duodenum
|
36 |
chr9:110349800-110350400 |
Enhancers |
Esophagus |
oesophagus
|
37 |
chr9:110349800-110350400 |
Flanking Active TSS |
Placenta |
Placenta
|
38 |
chr9:110349800-110350800 |
Weak transcription |
Right Atrium |
heart
|
39 |
chr9:110349800-110350800 |
Weak transcription |
Skeletal Muscle Male |
skeletal muscle
|
40 |
chr9:110349800-110351000 |
Enhancers |
Fetal Muscle Trunk |
muscle
|